On January 5, APMA submitted comments to CMS Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs Proposed Rule, and in particular to respond to the proposed rule referenced above addressing supplemental benefits for the chronically ill and prior authorization.
APMA is deeply saddened to share that Past President Terence Albright, DPM, passed away at the end of December. He was the 2005 recipient of the APMA Distinguished Service Citation, APMA's highest honor.
Last month, APMA submitted comments to the Office of the National Coordinator for Health Information Technology (ONC) and CMS, in response to the proposed rule, “21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking Proposed Rule.”
In December 2023, Sarah Abshier, DPM, APMA’s CPT alternate advisor, was appointed to serve a four-year term representing the Health Care Professional Advisory Committee (HCPAC) on the CPT Editorial Panel.
The APMA Center for Professional Advocacy (CPA) is delighted to announce that it is awarding six state components 2024 Innovation Grants, as well as awarding two states 2024 Financial Assistance Grants.
Following comments from APMA (submitted in conjunction with AAD) and testimony from Palmetto state CAC representatives, Palmetto has modified the restrictions it proposed in its Proposed Surgical Treatment of Nails Policies, which take effect January 21, 2024.
Do you want data that can help you negotiate a higher salary in your next job or benchmark your own performance? APMA is delighted to continue its yearly partnership with MGMA, offering valuable data to our members.
APMA Executive Director and CEO James R. Christina, DPM, has announced that he will retire on March 31, 2024. Dr. Christina has been executive director since 2015, and previously served as director of Scientific Affairs for a decade.
APMA previously shared that effective January 1, 2024, ready-to-wear, gradient compression garments will be covered for the treatment of lymphedema, including in the absence of an open ulcer.
Last week, APMA submitted comments providing feedback on the current Healthy People 2030 objectives set by the US Department of Health and Human Services Office of Disease Prevention and Health Promotion.
The Clinician Practice Information (CPI) Survey, a partner survey to the Physician Information Survey (PPI) will soon be underway, and APMA members are encouraged to engage in this effort.
APMA Executive Director and CEO, James R. Christina, DPM, has an important update for members about APMA headquarters.
On November 16, Paul Kesselman, DPM, Health Policy and Practice Committee member and chair of APMA’s DME Workgroup, presented remarks representing the American Podiatric Medical Association during the National Institutes of Health (NIH) Diabetes Mellitus Interagency Coordination Committee (DMICC) meeting.
The 23rd Annual CAC-PIAC Representatives Meeting was held in Alexandria, VA, on Friday, November 10. More than 50 volunteer member leaders from across the country gathered for education and collaboration.
Following APMA advocacy, CMS rescinded the regulations regarding appropriate use criteria for advanced diagnostic imaging in the 2024 Physician Fee Schedule Final Rule.
APMA recently submitted comments to the Office for Civil Rights (OCR) under the Department of Health and Human Services (HHS), in response to its proposed rule, “Discrimination on the Basis of Disability in Health and Human Service Programs or Activities.”
As an APMA member, you have access to several complimentary CECH courses through the APMA Online Learning Center. Check out these recent additions.
APMA has heard from several members that for the 2022 performance year, they received a score for the MIPS cost category. Specifically, members were scored on the Diabetes episode-based cost measure, which in some cases negatively impacted their overall performance for 2022, which could reduce their Medicare payments in 2024.
CMS released the CY 2024 Medicare Physician Fee Schedule (MPFS) Final Rule on November 2. APMA is currently reviewing the rule and will provide full analysis, as necessary.
Following advocacy by APMA and others, effective January 1, 2024, ready-to-wear, gradient compression garments will be covered for the treatment of lymphedema in the absence of an open ulcer.